Literature DB >> 7675324

Allopurinol protects against manganese-induced oxidative stress in the striatum and in the brainstem of the rat.

M S Desole1, G Esposito, R Migheli, L Fresu, S Sircana, M Miele, G De Natale, E Miele.   

Abstract

Levels of uric acid, xanthine, hypoxanthine, ascorbic acid (AA), dehydroascorbic acid, glutathione (GSH), noradrenaline (NA), dopamine (DA), dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA) and and 3-methoxytyramine were determined in the striatum and/or in the brainstem of 3-month-old male Wistar rats given manganese (MnCl2, 200 mg/kg/day for 7 days by gavage) alone or associated with allopurinol. Allopurinol alone (300 mg/kg/day for 4 days by gavage) decreased uric acid and increased xanthine levels both in the striatum and in the brainstem; moreover, allopurinol decreased the striatal DOPAC + HVA/DA ratio. Allopurinol antagonised the Mn-induced: (a) increase in the DOPAC + HVA/DA ratio; (b) increase in uric acid levels and AA oxidation; and (c) decrease in GSH and NA levels. We conclude that allopurinol may protect against Mn-induced oxidative stress by inhibiting both DA oxidative metabolism and xanthine oxidase-mediated formation of reactive oxygen species.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7675324     DOI: 10.1016/0304-3940(95)11613-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  Allopurinol reduces levels of urate and dopamine but not dopaminergic neurons in a dual pesticide model of Parkinson's disease.

Authors:  Anil Kachroo; Michael A Schwarzschild
Journal:  Brain Res       Date:  2014-03-26       Impact factor: 3.252

2.  Ontogenetic exposure of rats to pre- and post-natal manganese enhances behavioral impairments produced by perinatal 6-hydroxydopamine.

Authors:  Przemysław Nowak; Kamila Bojanek; Ryszard Szkilnik; Jadwiga Jośko; Dariusz Boroń; Marta Adwent; Piotr Gorczyca; Richard M Kostrzewa; Ryszard Brus
Journal:  Neurotox Res       Date:  2010-04-06       Impact factor: 3.911

3.  Manganese-induced neurotoxicity is differentially enhanced by glutathione depletion in astrocytoma and neuroblastoma cells.

Authors:  Vikas V Dukhande; Gauri H Malthankar-Phatak; Jeremy J Hugus; Christopher K Daniels; James C K Lai
Journal:  Neurochem Res       Date:  2006-10-20       Impact factor: 3.996

4.  Effect of pre- and postnatal manganese exposure on brain histamine content in a rodent model of Parkinson's disease.

Authors:  Ryszard Brus; Jerzy Jochem; Przemysław Nowak; Marta Adwent; Dariusz Boroń; Halina Brus; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2011-08-06       Impact factor: 3.911

5.  Manganese decreases glutamate uptake in cultured astrocytes.

Authors:  A S Hazell; M D Norenberg
Journal:  Neurochem Res       Date:  1997-12       Impact factor: 3.996

6.  Intranasal exposure to manganese disrupts neurotransmitter release from glutamatergic synapses in the central nervous system in vivo.

Authors:  Andrew H Moberly; Lindsey A Czarnecki; Joseph Pottackal; Tom Rubinstein; Daniel J Turkel; Marley D Kass; John P McGann
Journal:  Neurotoxicology       Date:  2012-04-20       Impact factor: 4.294

7.  Manganese inhalation as a Parkinson disease model.

Authors:  José Luis Ordoñez-Librado; Verónica Anaya-Martínez; Ana Luisa Gutierrez-Valdez; Laura Colín-Barenque; Enrique Montiel-Flores; Maria Rosa Avila-Costa
Journal:  Parkinsons Dis       Date:  2010-12-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.